From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA panel urges review of stent

from The Wall Street Journal

A federal advisory panel has decided there isn't enough evidence to support keeping Stryker's Wingspan stent on the market, raising the possibility the Food and Drug Administration might withdraw its approval of the stroke-treatment product. The device is used in fewer than 2,000 patients a year who have had multiple strokes from intracranial-artery blockage. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063